Table 1.
Laboratory findings at first visit to our hospital
| Hematology | Blood chemistry | Viral markers | Immunology | Coagulation | |||||
| WBC | 7400/μL | TP | 7.4 g/dL | Anti-HA IgM | (-) | IgA | 183 mg/dL | PT% | 95% |
| Neutrophil | 72.0% | Albumin | 4.5 g/dL | Anti-HCV | (-) | IgG | 1168 mg/dL | APTT | 36.4 s |
| Eosinophil | 1.0% | T-Bil | 11.1 mg/dL | HBsAg | (+) 197333 | IgM | 220 mg/dL | ||
| Basophil | 0.0% | D-Bil | 8.0 mg/dL | Anti-HBc IgM | (+) 25.5 C.O.I | ANA | × 40, homogeneous | ||
| Monocyte | 10.0% | AST | 1942 IU/L | HBeAg | (+) 253 C.O.I | ||||
| Lymphocyte | 17.0% | ALT | 2963 IU/L | Anti-HBe | (-) 0.0 % | ||||
| RBC | 457/μL | ALP | 612 IU/L | HBV-DNA | 7.7 log copies/mL | ||||
| Hemoglobin | 16.0 g/dL | γGTP | 756 IU/L | Anti-HIV | (-) | ||||
| Hematocrit | 46.4% | LDH | 739 IU/L | RPR | (-) | ||||
| Platelet | 36.6 × 104/μL | BUN | 8.2 mg/dL | TPHA | (+) | ||||
| Creatinine | 0.64 mg/dL | Anti-CMV IgG | (+) | ||||||
| T-Chol | 225 mg/dL | Anti-CMV IgM | (-) | ||||||
| Anti-EBV EBNA | (+) | ||||||||
| Anti-EBV EA IgG | (-) | ||||||||
| Anti-EBV VCA IgG | (+) | ||||||||
| Anti-EBV VCA IgM | (-) | ||||||||
WBC: White blood cells; RBC: Red blood cells; ANA: Antinuclear antibody; TP: Total protein; T-Bil: Total bilirubin; D-Bil: Direct bilirubin; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; ALP: Alkaline phosphatase; γGTP: γ-glutamyltranspeptidase; LDH: Lactase dehydrogenase; BUN: Blood urea nitrogen; T-Chol: Total cholesterol; PT: Prothrombin activity; APTT: Activated partial thromboplastin time; C.O.I: Cutoff index; HA: Hepatitis A; HCV: Hepatitis C virus; HBsAg: Hepatitis B surface antigen; HBc: Hepatitis B core; HBeAg: Hepatitis B e-antigen; HBV: Hepatitis B virus; HIV: Human immunodeficiency virus; RPR: Rapid plasma regain; TPHA: Treponema pallidum hemagglutination assay; CMV: Cytomegalovirus; EBV: Epstein-Barr virus; EBNA: Epstein-Barr virus nuclear antigen; EA: Early antigen; VCA: Viral capsid antigen.